Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesClinical/Medical PolicyBluecross Idaho Evenity Prior Auth | OpenPayer
    Ask Trek AI about this page
    CurrentBluecross IdahoPolicy MP 5.01.675

    Evenity (romosozumab-aqqg) for Postmenopausal Osteoporosis

    Customize your policy alerts

    Sign up for Bluecross Idaho Policy MP 5.01.675 alerts

    Get alerted when Policy MP 5.01.675 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Medical-benefit coverage and prior authorization for Evenity in postmenopausal females with osteoporosis who meet specified fracture-risk, prior-therapy, combination-use, duration, and dosing requirements. Pharmacy-benefit requests are outside this policy's scope.

    Policy Summary
    PayerBluecross Idaho
    PolicyEvenity (romosozumab-aqqg) for Postmenopausal Osteoporosis
    Policy CodePolicy N/A
    Change TypeNew policy
    Effective DateJuly 1, 2026
    Last ReviewMar 26, 2026
    Next Review DateN/A
    Key ActionPrior authorization is required for Evenity requests under the medical benefit.
    SourceLink
    POLICY UPDATE CHANGES

    Blue Cross of Idaho added a new prescription-drug policy establishing coverage criteria for Evenity in postmenopausal women with osteoporosis.

    12 monthsMaximum lifetime treatment
    210 mg monthlyRecommended dose
    ≤ -2.5Qualifying osteoporosis BMD
    >30% / >4.5%Very high FRAX thresholds

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    3Prior alternative-therapy categories